151 related articles for article (PubMed ID: 24248146)
1. Synthesis and dual histamine H₁ and H₂ receptor antagonist activity of cyanoguanidine derivatives.
Sadek B; Alisch R; Buschauer A; Elz S
Molecules; 2013 Nov; 18(11):14186-202. PubMed ID: 24248146
[TBL] [Abstract][Full Text] [Related]
2. Combined histamine H1/H2 receptor antagonists: part I. Pharmacological hybrids with pheniramine- and roxatidine-like substructures.
Schulze FR; Buschauer A; Schunack W
Eur J Pharm Sci; 1998 Jul; 6(3):177-86. PubMed ID: 9795048
[TBL] [Abstract][Full Text] [Related]
3. Combined histamine H1/H2 receptor antagonists: part II. Pharmacological hybrids with pheniramine- and tiotidine-like substructures.
Wolf C; Schulze FR; Buschauer A; Schunack W
Eur J Pharm Sci; 1998 Jul; 6(3):187-96. PubMed ID: 9795053
[TBL] [Abstract][Full Text] [Related]
4. [Synthesis and combined H1-/H2 antagonist activity of mepyramine, pheniramine and cyclizine derivatives with cyanoguanidine, urea and nitroethenediamine partial structures].
Schulze FR; Alisch RA; Buschauer A; Schunack W
Arch Pharm (Weinheim); 1994 Jul; 327(7):455-62. PubMed ID: 7915515
[TBL] [Abstract][Full Text] [Related]
5. Iodoaminopotentidine and related compounds: a new class of ligands with high affinity and selectivity for the histamine H2 receptor.
Hirschfeld J; Buschauer A; Elz S; Schunack W; Ruat M; Traiffort E; Schwartz JC
J Med Chem; 1992 Jun; 35(12):2231-8. PubMed ID: 1613748
[TBL] [Abstract][Full Text] [Related]
6. [Quinazolinones. 18. Synthesis and H1/H2-antihistaminic action of omega-[2-aryl-2,3-dihydro-4(1H)-quinazolinone-1-yl]alkyl substituted ureas and cyanoguanidines].
Büyüktimkin S; Buschauer A; Schunack W
Arch Pharm (Weinheim); 1991 May; 324(5):291-5. PubMed ID: 1679625
[TBL] [Abstract][Full Text] [Related]
7. Theoretical studies on the histamine H2 receptor: molecular mechanism of action of antagonists.
Giraldo J; Martín M; Campillo M; Pardo L
Mol Pharmacol; 1992 Aug; 42(2):373-81. PubMed ID: 1355265
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and pharmacology of combined histamine H1-/H2-receptor antagonists containing diphenhydramine and cyproheptadine derivatives.
Wolf C; Schunack W
Arch Pharm (Weinheim); 1996 Feb; 329(2):87-94. PubMed ID: 8851472
[TBL] [Abstract][Full Text] [Related]
9. A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine.
Cavanagh RL; Usakewicz JJ; Buyniski JP
J Pharmacol Exp Ther; 1983 Jan; 224(1):171-9. PubMed ID: 6129316
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and histamine H2-receptor antagonist activity of 4-(1-pyrazolyl)butanamides, guanidinopyrazoles, and related compounds.
Buschauer A; Mohr R; Schunack W
Arch Pharm (Weinheim); 1995 Apr; 328(4):349-58. PubMed ID: 7611832
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and in vitro pharmacology of arpromidine and related phenyl(pyridylalkyl)guanidines, a potential new class of positive inotropic drugs.
Buschauer A
J Med Chem; 1989 Aug; 32(8):1963-70. PubMed ID: 2569042
[TBL] [Abstract][Full Text] [Related]
12. Conformational requirements for histamine H2-receptor inhibitors: a structure-activity study of phenylene analogues related to cimetidine and tiotidine.
Hoffman JM; Pietruszkiewicz AM; Habecker CN; Phillips BT; Bolhofer WA; Cragoe EJ; Torchiana ML; Lumma WC; Baldwin JJ
J Med Chem; 1983 Feb; 26(2):140-4. PubMed ID: 6131129
[TBL] [Abstract][Full Text] [Related]
13. Structural studies on H2-antagonists: crystal and molecular structure of N-cyano-N'-methyl-N"-(2-[(2-amino-5-thiazolyl)methylthio]ethyl) guanidine and N-cyano-3-[(2-guanidino-5-thiazolyl)methylthio]propionamidine.
Ianelli S; Pelizzi G
Farmaco; 1992 May; 47(5):607-21. PubMed ID: 1356342
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological profiles of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy] propyl] urea.
Sekiguchi H; Hamada K; Kobayashi F; Taga F; Uchida H
Arzneimittelforschung; 1993 Feb; 43(2):129-33. PubMed ID: 8096132
[TBL] [Abstract][Full Text] [Related]
15. Cyanoguanidine-thiourea equivalence in the development of the histamine H2-receptor antagonist, cimetidine.
Durant GJ; Emmett JC; Ganellin CR; Miles PD; Parsons ME; Prain HD; White GR
J Med Chem; 1977 Jul; 20(7):901-6. PubMed ID: 17751
[TBL] [Abstract][Full Text] [Related]
16. Histamine H2 receptor antagonists. 1. Synthesis of N-cyano and N-carbamoyl amidine derivatives and their biological activities.
Yanagisawa I; Hirata Y; Ishii Y
J Med Chem; 1984 Jul; 27(7):849-57. PubMed ID: 6145803
[TBL] [Abstract][Full Text] [Related]
17. [Impromidine-analogous guanidines: synthesis and activity at the histamine H2-receptor. 29. Histamine analogs].
Elz S; Schunack W
Arzneimittelforschung; 1988 Mar; 38(3):327-32. PubMed ID: 2898245
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and pharmacological activity of fluorescent histamine H2 receptor antagonists related to potentidine.
Li L; Kracht J; Peng S; Bernhardt G; Elz S; Buschauer A
Bioorg Med Chem Lett; 2003 May; 13(10):1717-20. PubMed ID: 12729649
[TBL] [Abstract][Full Text] [Related]
19. Zwitterionic analogues of cimetidine as H2 receptor antagonists.
Young RC; Ganellin CR; Graham MJ; Mitchell RC; Roantree ML; Tashma Z
J Med Chem; 1987 Jul; 30(7):1150-6. PubMed ID: 2885416
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of histamine H1- and H2-receptors in guinea-pig left atrial membranes by [3H]-mepyramine and [3H]-tiotidine binding.
Hattori Y; Endou M; Gando S; Kanno M
Br J Pharmacol; 1991 Jun; 103(2):1573-9. PubMed ID: 1909203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]